Wednesday, August 23, 2017 3:27:34 PM
HealthDatix Channel Partner Signs Two Contracts Utilizing the HealthDatix Platform
9:08 am ET August 23, 2017 (Market Wire) Print
SMITHTOWN, NY--(Marketwired - Aug 23, 2017) - iGambit Inc. (OTCQB: IGMB) is pleased to announce that one of its Channel Partners has signed two contracts, utilizing the HealthDatix platform, with two large mid-western health systems. The contracts are with the Primary Care Physicians practices that are affiliates of the hospital systems. The practices have approximately 25,000 patients.
Our focus is on developing a strong distribution platform by working with vendor partners and Channel Partners to facilitate the implementation of the HealthDatix platform to provide medical organizations with an easy to use full service solution to perform Annual Wellness Visits (AWV), Health Risk Assessment (HRA) and initiate Personal Prevention Plans (PPP). Health Risk Assessments have been implemented by Medicare to insure that patients receive care that increases their overall health while at the same time decreases their incidents of readmission due to chronic illness.
John Salerno, Chairman of iGambit, stated, "I am extremely pleased that our HealthDatix team has successfully initiated the process of rollout for our healthcare program. These contracts represent just the beginning of our national rollout and I expect that our team will continue our HealthDatix rollout at a swift pace throughout this quarter."
About iGambit Inc: iGambit (OTCQB: IGMB) is a fully reporting publicly held company. We are a company focused on pursuing specific medical strategies and objectives. These objectives have included, among others, the acquisition of medical technology companies with strong growth potential easily recognized in the public arena. We believe that the background of our management and of our Board of Directors in the technology markets is a valuable resource that makes us a desirable business partner. We expect to work to assume an active role in the development and growth of the new company, providing both strategic guidance and operational support. The management of iGambit believes that it can leverage its collective expertise to help position the combined company to produce high-margin, recurring and predictable earnings and generate long-term value for our stockholders. For more information, please visit www.igambit.com. Information on our web-site does not comprise a part of this press release.
Cautionary Note Regarding Forward-Looking Statements
Certain statements in this document and elsewhere by iGambit are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such information includes, without limitation, the business outlook, assessment of market conditions, anticipated financial and operating results, strategies, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward- looking statements include, but are not limited to fluctuations in demand; changes to economic growth in the U.S. and U.S. government policies and regulations, including, but not limited to those affecting the medical fertility clinic industry. iGambit undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in iGambit Inc.'s filings with the Securities and Exchange Commission.
Investor Relations Contacts: Bill Robertson Ph. No. 604 837 3835
Recent NUTX News
- NUTEX HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS • PR Newswire (US) • 05/08/2024 11:13:00 PM
- NUTEX HEALTH SCHEDULES 2024 FIRST QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL • PR Newswire (US) • 05/07/2024 09:30:00 AM
- NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2024 ANNUAL MEETING • PR Newswire (US) • 05/06/2024 10:35:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 09:21:52 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 08:49:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/06/2024 08:46:16 PM
- NUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCE • PR Newswire (US) • 04/29/2024 09:30:00 AM
- NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS • PR Newswire (US) • 04/22/2024 09:30:00 AM
- Nutex Health Hospitals Gain Community Recognition and Take Home Seven Patient Satisfaction Awards in Q1 • PR Newswire (US) • 04/16/2024 09:30:00 AM
- NUTEX HEALTH PROVIDES CORPORATE UPDATE • PR Newswire (US) • 04/12/2024 09:30:00 AM
- NUTEX HEALTH OPENS FIRST HOSPITAL OF 2024 IN BELLEVUE, WISCONSIN • PR Newswire (US) • 04/08/2024 09:30:00 AM
- NUTEX HEALTH ANNOUNCES 1-FOR-15 REVERSE STOCK SPLIT • PR Newswire (US) • 04/05/2024 09:30:00 AM
- NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS • PR Newswire (US) • 03/28/2024 10:56:00 PM
- NUTEX HEALTH ANNOUNCES PRELIMINARY 2023 HEADLINE FINANCIALS AND PROVIDES UPDATE ON THE TIMING OF ITS 10-K FILING • PR Newswire (US) • 03/15/2024 09:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:37:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:53:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:59:29 PM
- NUTEX HEALTH ANNOUNCES OVER 100% INCREASE IN MEDICARE ADVANTAGE ENROLLMENT • PR Newswire (US) • 02/05/2024 10:30:00 AM
- /C O R R E C T I O N -- Nutex Health, Inc./ • PR Newswire (US) • 01/31/2024 10:30:00 AM
- NUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLAN • PR Newswire (US) • 01/30/2024 10:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/24/2024 09:50:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:45:43 PM
- Nutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and Warrants • PR Newswire (US) • 01/23/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 03:59:19 PM
- NUTEX HEALTH TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE • PR Newswire (US) • 12/18/2023 10:30:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM